General Information of Drug (ID: DMT6O2E)

Drug Name
NC318 Drug Info
Indication
Disease Entry ICD 11 Status REF
Non-small-cell lung cancer 2C25 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMT6O2E

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sialic acid-binding immunoglobulin-like lectin 15 (SIGLEC15) TTBSZPF SIG15_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT04699123) The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of NextCure.